Cingulate Therapeutics

0 followers


Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.

Industries

Headquarters

Stage

Employees

Links

Org chart

Shane J. Schaffer
Chairman & CEO

Shane J. Schaffer

Collapse
Raul R. Silva
Chief Science Officer
Matthew Brams
Chief Medical Officer
Arthur Straughn
Co-founder Board of Directors
Jeff Bennett
Deputy General Counsel
Naama Courtemanche
Vp, Operations And Quality Assurance
Thomas Dalton
Vice President, Investor & Public Relations; Vice President, Government Affairs
Jennifer Callahan
Svp, Chief Financial Officer